Seven Insurance Regulatory Issues That Frequently Arise in Private Equity Transactions

Short summary

This article outlines seven key regulatory issues that arise when private equity firms invest in insurance-sector businesses, including varying licensing requirements across entity types, insurance holding company act triggers, hidden licensing issues for producers and MGAs, capital management constraints, affiliate transaction scrutiny, investment activity limitations, and exit-planning considerations. Each issue can materially affect deal timing, structure, and post-closing integration. The piece serves as a practical diligence checklist for transaction counsel and PE sponsors entering the insurance market.

• •Insurance businesses face varying state-level regulatory requirements depending on entity type and jurisdiction
• •Acquisitions of insurers trigger holding company act filings, capital distribution approvals, and affiliate transaction scrutiny
• •Exit planning must account for regulatory constraints from the outset of the acquisition

Generated with AI, which can make mistakes.